in Health care
Syngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panel
New Delhi: Stating that the proposal submitted by Syngene International could not be considered at present, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the proposal to conduct the Phase I clinical trial of Ferumoxytol injection. The drug to be used in the proposed trial is not […] More
